pancreatic cancer

News

Revolution Medicines thinks it could transform the treatment of pancreatic cancer based on phase 3 data with its pan-RAS(on) inhibitor daraxonrasib.

Oncology

Immuneering's Ben Zeskind explains how, by focusing on quality of life as well as quantity, they've created a drug for pancreatic cancer.

News

Procyon is hoping to launch a diagnostic test next year that will be able to detect people at risk of pancreatic cancer from a urine sample.

News

Astellas' effort to expand the reach of its first-in-class claudin 18.2 drug Vyloy into pancreatic cancer has had a major setback.

News

The NHS has started a pilot project that will sift through patient records to try to detect people at risk of pancreatic cancer.

Oncology

Discover how Tumour Treating Fields are transforming pancreatic cancer treatment with insights from Dr. Vincent Picozzi at ASCO 2025.